PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 8688344-1 1996 A combination of cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) has been a standard therapy for histologically aggressive non-Hodgkin"s lymphomas for over 20 years, but several newer regimens, referred to as second or third generation, have been reported to give improved results in single-centre studies. Cyclophosphamide 17-33 DNA damage inducible transcript 3 Homo sapiens 78-82 8688344-1 1996 A combination of cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) has been a standard therapy for histologically aggressive non-Hodgkin"s lymphomas for over 20 years, but several newer regimens, referred to as second or third generation, have been reported to give improved results in single-centre studies. Doxorubicin 35-46 DNA damage inducible transcript 3 Homo sapiens 78-82 8688344-1 1996 A combination of cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) has been a standard therapy for histologically aggressive non-Hodgkin"s lymphomas for over 20 years, but several newer regimens, referred to as second or third generation, have been reported to give improved results in single-centre studies. Prednisolone 64-76 DNA damage inducible transcript 3 Homo sapiens 78-82